154 related articles for article (PubMed ID: 32160410)
21. Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL.
Smyth L; Browne PV; Conneally E; Flynn C; Hayden P; Jeffers M; O'Brien D; Quinn F; Kelly J; Perera M; Crotty GM; Leahy M; Hennessy B; Jackson F; Ryan M; Vandenberghe E
Ir J Med Sci; 2016 Nov; 185(4):773-777. PubMed ID: 25843016
[TBL] [Abstract][Full Text] [Related]
22. A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience.
Jang SJ; Yoon DH; Kim S; Yoon S; Kim DY; Park CS; Huh J; Lee SW; Lee DH; Ryu JS; Suh C
Ann Hematol; 2012 Dec; 91(12):1917-22. PubMed ID: 22864762
[TBL] [Abstract][Full Text] [Related]
23. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
24. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
van Imhoff GW; van der Holt B; MacKenzie MA; Ossenkoppele GJ; Wijermans PW; Kramer MH; van 't Veer MB; Schouten HC; van Marwijk Kooy M; van Oers MH; Raemaekers JM; Sonneveld P; Meulendijks LA; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
Leukemia; 2005 Jun; 19(6):945-52. PubMed ID: 15800666
[TBL] [Abstract][Full Text] [Related]
25. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
26. Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
Baleydier F; Pondarre C; Pages MP; Mialou V; Kebaili K; Pracros JP; Bertrand Y
J Pediatr Hematol Oncol; 2008 Dec; 30(12):972-5. PubMed ID: 19131795
[TBL] [Abstract][Full Text] [Related]
27. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
[TBL] [Abstract][Full Text] [Related]
28. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005.
Mbulaiteye SM; Anderson WF; Bhatia K; Rosenberg PS; Linet MS; Devesa SS
Int J Cancer; 2010 Apr; 126(7):1732-9. PubMed ID: 19810101
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies.
Della Rocca AM; Leonart LP; Ferreira VL; Tonin FS; Steffenello-Durigon G; Del Moral JAG; Fernandez-Llimos F; Pontarolo R
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):514-525. PubMed ID: 33947633
[TBL] [Abstract][Full Text] [Related]
30. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
[TBL] [Abstract][Full Text] [Related]
31. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.
Choi MK; Jun HJ; Lee SY; Kim KH; Lim DH; Kim K; Ko YH; Kim WS; Kim SJ
Ann Hematol; 2009 Nov; 88(11):1099-106. PubMed ID: 19288103
[TBL] [Abstract][Full Text] [Related]
32. Burkitt Lymphoma International Prognostic Index.
Olszewski AJ; Jakobsen LH; Collins GP; Cwynarski K; Bachanova V; Blum KA; Boughan KM; Bower M; Dalla Pria A; Danilov A; David KA; Diefenbach C; Ellin F; Epperla N; Farooq U; Feldman TA; Gerrie AS; Jagadeesh D; Kamdar M; Karmali R; Kassam S; Kenkre VP; Khan N; Kim SH; Klein AK; Lossos IS; Lunning MA; Martin P; Martinez-Calle N; Montoto S; Naik S; Palmisiano N; Peace D; Phillips EH; Phillips TJ; Portell CA; Reddy N; Santarsieri A; Sarraf Yazdy M; Smeland KB; Smith SE; Smith SD; Sundaram S; Zayac AS; Zhang XY; Zhu C; Cheah CY; El-Galaly TC; Evens AM
J Clin Oncol; 2021 Apr; 39(10):1129-1138. PubMed ID: 33502927
[TBL] [Abstract][Full Text] [Related]
33. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
Galicier L; Fieschi C; Borie R; Meignin V; Daniel MT; Gérard L; Oksenhendler E
Blood; 2007 Oct; 110(8):2846-54. PubMed ID: 17609431
[TBL] [Abstract][Full Text] [Related]
34. [Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience].
Baryakh EA; Tyurina NG; Vorobyev VI; Gemdzhyan EG; Mangasarova YK; Klyasova GA; Kovrigina AM; Obukhova TN; Zvonkov EE; Vernyuk MA; Chervontseva AM; Polyakov YY; Misyurina АЕ; Valiev TT; Zherebtsova VA; Magomedova AU; Galstyan GM; Yatskov KV; Nesterova ES; Vorobyev AI; Kravchenko SK
Ter Arkh; 2015; 87(7):4-14. PubMed ID: 26390720
[TBL] [Abstract][Full Text] [Related]
35. [Long term efficacy of COPADM regimen in the treatment of 20 patients with Burkitt lymphoma].
Yang D; Wang P; Chen J; Li CX; Zhang Y; Chen XC; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):645-649. PubMed ID: 30180465
[No Abstract] [Full Text] [Related]
36. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.
Magrath IT; Janus C; Edwards BK; Spiegel R; Jaffe ES; Berard CW; Miliauskas J; Morris K; Barnwell R
Blood; 1984 May; 63(5):1102-11. PubMed ID: 6546890
[TBL] [Abstract][Full Text] [Related]
37. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
38. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
[TBL] [Abstract][Full Text] [Related]
39. Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in India.
Srinivasan S; Roy Moulik N; Kc A; Narula G; Sankaran H; Prasad M; Dhamne C; Cheriyalinkal Parambil B; Shah S; Shet T; Sridhar E; Gujral S; Banavali S
Pediatr Blood Cancer; 2020 Nov; 67(11):e28682. PubMed ID: 32865865
[TBL] [Abstract][Full Text] [Related]
40. The role of surgical management in primary small bowel lymphoma: A single-center experience.
Hong YW; Kuo IM; Liu YY; Yeh TS
Eur J Surg Oncol; 2017 Oct; 43(10):1886-1893. PubMed ID: 28751057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
